GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
J

Johnson Chemical Pharmaceutical Works Co 4747.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

19.45

-9.95%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 569.8m

FY2016FY2025

Net income

TWD 53.5m

FY2016FY2025

Free cash flow

TWD 7.7m

FY2016FY2025

Shareholders' equity

TWD 1.71bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 569.8mTWD 611.4mTWD 606.7mTWD 494.7mTWD 411.5mTWD 424.0mTWD 425.3mTWD 411.9mTWD 394.6mTWD 392.4m
Gross profitTWD 228.3mTWD 248.0mTWD 244.6mTWD 204.4mTWD 171.9mTWD 192.2mTWD 191.4mTWD 176.8mTWD 169.2mTWD 179.4m
Research and developmentTWD 16.0mTWD 20.8mTWD 17.3mTWD 13.3mTWD 8.9mTWD 13.1mTWD 9.8mTWD 9.3mTWD 6.9mTWD 9.7m
Operating incomeTWD 73.1mTWD 98.0mTWD 98.9mTWD 82.7mTWD 62.3mTWD 75.5mTWD 78.8mTWD 68.8mTWD 66.4mTWD 72.5m
Net incomeTWD 53.5mTWD 84.1mTWD 79.7mTWD 64.9mTWD 49.1mTWD 63.6mTWD 64.5mTWD 57.3mTWD 60.0mTWD 63.4m
Diluted earnings per share1.201.881.832.161.642.122.151.281.341.42

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 2.09bnTWD 1.97bnTWD 1.99bnTWD 1.04bnTWD 1.03bnTWD 1.10bnTWD 951.8mTWD 936.8mTWD 931.1mTWD 955.5m
Total liabilitiesTWD 384.4mTWD 261.4mTWD 321.0mTWD 167.6mTWD 178.9mTWD 240.3mTWD 103.8mTWD 100.3mTWD 95.6mTWD 123.1m
Debt—TWD 90.2mTWD 100.8m———————
Shareholders' equityTWD 1.71bnTWD 1.70bnTWD 1.67bnTWD 871.7mTWD 848.2mTWD 858.2mTWD 848.0mTWD 836.5mTWD 835.4mTWD 832.4m
Shares outstanding45m45m44m30m30m30m30m45m45m45m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 71.7mTWD 62.9mTWD 136.9mTWD 89.7mTWD 52.3mTWD 71.8mTWD 71.5mTWD 68.2mTWD 39.9mTWD 68.2m
Capital spending−TWD 64.0m−TWD 13.2m−TWD 33.1m−TWD 59.7m−TWD 37.3m−TWD 162.2m−TWD 15.1m−TWD 7.3m−TWD 3.7m−TWD 95.4m
Free cash flowTWD 7.7mTWD 49.7mTWD 103.8mTWD 30.0mTWD 15.1m−TWD 90.4mTWD 56.4mTWD 60.8mTWD 36.2m−TWD 27.1m
Dividends paid−TWD 78.6m−TWD 67.3m−TWD 60.0m−TWD 43.5m−TWD 57.6m−TWD 54.0m−TWD 49.5m−TWD 54.0m−TWD 57.0m−TWD 52.5m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 146.5mTWD 146.6mTWD 150.5mTWD 134.3mTWD 138.2mTWD 146.8mTWD 147.8mTWD 150.0m
Gross profitTWD 54.5mTWD 58.3mTWD 59.4mTWD 54.8mTWD 55.1mTWD 59.0mTWD 60.7mTWD 61.4m
Operating incomeTWD 15.7m—TWD 13.9mTWD 14.1mTWD 20.4mTWD 24.7mTWD 21.3mTWD 27.6m
Net incomeTWD 10.4mTWD 66.3m−TWD 2.9mTWD 15.6mTWD 19.3mTWD 21.6mTWD 19.9mTWD 21.2m
Diluted earnings per share0.231.48-0.070.350.430.480.450.47
Cash from operationsTWD 14.0m−TWD 20.0mTWD 9.0mTWD 21.0mTWD 4.0mTWD 37.0mTWD 17.0mTWD 15.0m
Capital spending−TWD 12.0m−TWD 8.0m−TWD 20.0m−TWD 24.0m−TWD 10.0m−TWD 8.0m−TWD 1.0m−TWD 1.0m
Free cash flowTWD 2.0m−TWD 28.0m−TWD 11.0m−TWD 3.0m−TWD 6.0mTWD 29.0mTWD 16.0mTWD 14.0m
Total assetsTWD 2.56bnTWD 3.08bnTWD 2.09bnTWD 1.99bnTWD 2.00bnTWD 1.99bnTWD 1.97bnTWD 1.95bn
Debt—————TWD 90.7mTWD 90.2mTWD 89.7m
Shareholders' equityTWD 1.74bnTWD 1.77bnTWD 1.71bnTWD 1.71bnTWD 1.67bnTWD 1.73bnTWD 1.70bnTWD 1.68bn

Financial ratios

Data as of 27 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2017FY2016
Gross margin40.1%40.6%40.3%41.3%41.8%45.3%———
Operating margin11.8%18.4%17.4%16.5%15.1%17.9%———
Net margin9.4%13.8%13.1%13.1%11.9%15.0%———
Return on equity3.1%4.9%4.8%7.4%5.8%7.4%———
Return on assets2.6%4.3%4.0%6.2%4.8%5.8%———
Free cash flow yield—7.4%16.9%21.6%13.0%33.9%12.5%——
Revenue growth-6.8%0.8%22.6%20.2%-3.0%-0.3%———
Earnings growth-36.4%5.5%22.9%32.1%-22.8%-1.4%———
Current ratio3.79x7.81x6.18x2.47x2.50x2.27x———
Debt to equity0.00x0.05x0.06x0.00x———0.00x0.00x
Equity ratio81.6%86.7%83.9%83.9%82.6%78.1%———
Interest coverage17.92x32.01x22.96x77.38x57.83x95.97x———
R&D as a share of sales2.8%3.4%2.8%2.7%2.2%3.1%———
Buybacks as a share of market value—-2.4%-45.5%0.0%0.0%0.0%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue4.8%6.1%4.1%
Operating income-4.0%-0.7%0.3%
Net income-6.2%-3.4%-1.5%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin40.3%40.5%41.4%42.8%
Operating margin14.5%15.5%15.7%16.6%
Net margin11.7%12.4%12.7%13.7%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings24.719.022.911.810.78.89.115.214.412.8
Price to sales2.32.63.01.61.31.31.42.12.22.1

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 26 Jun 2025.

FY2025FY2024FY2023FY2022
Paid in the year0.8750.7491.000.657
  • 1125-for-1000 split · 30 Jul 2014
  • 1.125-for-1 split · 18 Jul 2013
  • 1.125-for-1 split · 30 Jul 2012

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.